Valneva SE (VALN) Total Debt Growth (1y) (2021 - 2026)
Valneva SE (VALN) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Valneva SE |
167.33 Mn |
44.10 Mn |
5.08 Mn |
13.08% |
| Date | Value |
|---|
| Mar 31, 2026 |
13.08% |
| Dec 31, 2025 |
4.16% |
| Sep 30, 2025 |
-24.30% |
| Jun 30, 2025 |
-28.71% |
| Mar 31, 2025 |
-1.69% |
| Dec 31, 2024 |
5.23% |
| Sep 30, 2024 |
44.31% |
| Jun 30, 2024 |
140.41% |
| Mar 31, 2024 |
93.40% |
| Dec 31, 2023 |
88.75% |
| Sep 30, 2023 |
23.79% |
| Jun 30, 2023 |
12.94% |
| Mar 31, 2023 |
65.80% |
| Dec 31, 2022 |
52.37% |
| Dec 31, 2021 |
3.98% |
